
Please try another search
(Reuters) -Walmart Inc and CVS Health Corp (NYSE:CVS) said on Wednesday they would stop filling prescriptions for controlled substances issued by telehealth startups Cerebral Inc and Done Health.
Cerebral and Done are known for treating patients with ADHD, prescribing stimulants such as Adderall.
Walmart (NYSE:WMT) confirmed the move to Reuters and said the decision was made after an audit and compliance process.
CVS said it would not accept prescriptions for controlled substances issued by the startups effective May 26, as a result of a review it conducted on the telehealth firms and after it was "unable to resolve concerns we have with Cerebral and Done Health."
Cerebral had earlier this month decided to stop prescribing controlled substances and taper existing prescriptions based on the impending expiration of waivers, the company said in an emailed statement.
The company was working to ensure that existing patients with controlled substance prescriptions are able to receive their medications, while working with the pharmacies to allow sufficient time to adjust to the changes, Cerebral said.
Cerebral said it plans to continue to prescribe controlled substances to treat opioid use disorder.
Done Health also said it would continue to provide prescriptions for psychiatric chronic care management.
"We expect this situation will be quickly resolved, if provided the opportunity, so patients can access the medications they have been prescribed using evidence based medicine," Done Health said on Thursday.
According to a Wall Street Journal report https://on.wsj.com/3MNn01f earlier this month, Cerebral had been issued a subpoena by federal prosecutors as part of an investigation into possible violations of the Controlled Substances Act.
(Reuters) - Global companies that make baby formula are bringing products into the United States after the country's health regulator relaxed its import policy to address a...
By Sam Boughedda According to a report by Bloomberg on Monday, Cathie Wood's ARK flagship fund, which is down significantly in 2022 fueled by Fed rate hikes, has gained its longest...
(Reuters) - Airlines canceled over 700 flights in the United States on Monday, as adverse weather and a shortage of staff hurt their ability to keep up with a surge in summer...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.